RheumaFinder Announces Investment by Novalis Biotech
Februari 2024 – RheumaFinder is excited to announce an investment from Belgium's Novalis Biotech Acceleration Fund. This investment, executed as a seed-participation in December 2023, marks a pivotal step in the company’s journey. RheumaFinder is at the forefront of revolutionizing…